|
|
|
Hypertension Clinical Trials |
|
Thank you for your interest in clinical trials for Hypertension
Please click "Search" to find Hypertension clinical trials and medical research studies.
If you receive too many study listings you may enter your zip code to find the locations closest to you.
|
|
|
|
|
Results from Clinical Connection:
|
|
|
|
Your search returned 16 studies:
|
|
|
|
|
Results from other databases:
|
|
Your search returned over 250 results. The top 250 results are being displayed. Please use
additional keywords or decrease the search distance. |
|
Your search returned 250 studies:
- 3-D Transcranial Ultrasound Analysis Study - NCT00239525-27710
Conditions: Cerebrovascular Accident, Intracranial Hypertension
Location: Durham, NC
- A Clinical Trial of Ambrisentan and Tadalafil in Pulmonary Arterial Hypertension Associated With Systemic Sclerosis - NCT01042158-21287
Conditions: Pulmonary Arterial Hypertension - Systemic Sclerosis - Scleroderma Spectrum of Diseases - Connective Tissue Disease - Pulmonary Hypertension
Location: Baltimore, MD
- A Collaborative Model to Improve Blood Pressure (BP) Control and Minimize Racial Disparities - NCT00935077-52242
Conditions: Hypertension - Asthma
Location: Iowa City, IA
- A Pharmacodynamic Study to Evaluate the Effect of a Fixed Dose Combination Pill on Blood Pressure - NCT01005290-
Conditions: Hypertension
Location: New York, NY
- A Phase 2 Study Of The 24-Hour Intraocular Pressure Lowering And Systemic Exposure Of PF-04217329 - NCT00934089-90013
Conditions: Glaucoma, Open-Angle - Ocular Hypertension
Location: Los Angeles, CA
- A Phase 2 Study Of The 24-Hour Intraocular Pressure Lowering And Systemic Exposure Of PF-04217329 - NCT00934089-90025
Conditions: Glaucoma, Open-Angle - Ocular Hypertension
Location: Los Angeles, CA
- A Phase 2 Study Of The 24-Hour Intraocular Pressure Lowering And Systemic Exposure Of PF-04217329 - NCT00934089-90057
Conditions: Glaucoma, Open-Angle - Ocular Hypertension
Location: Los Angeles, CA
- A Phase 2 Study Of The 24-Hour Intraocular Pressure Lowering And Systemic Exposure Of PF-04217329 - NCT00934089-90247
Conditions: Glaucoma, Open-Angle - Ocular Hypertension
Location: Gardena, CA
- A Phase 2 Study Of The 24-Hour Intraocular Pressure Lowering And Systemic Exposure Of PF-04217329 - NCT00934089-90505
Conditions: Glaucoma, Open-Angle - Ocular Hypertension
Location: Torrance, CA
- A Phase 2 Study Of The 24-Hour Intraocular Pressure Lowering And Systemic Exposure Of PF-04217329 - NCT00934089-90630
Conditions: Glaucoma, Open-Angle - Ocular Hypertension
Location: Cypress, CA
- A Phase 2 Study Of The 24-Hour Intraocular Pressure Lowering And Systemic Exposure Of PF-04217329 - NCT00934089-90806
Conditions: Glaucoma, Open-Angle - Ocular Hypertension
Location: Long Beach, CA
- A Phase 2 Study Of The 24-Hour Intraocular Pressure Lowering And Systemic Exposure Of PF-04217329 - NCT00934089-91105
Conditions: Glaucoma, Open-Angle - Ocular Hypertension
Location: Pasadena, CA
- A Phase 2 Study Of The 24-Hour Intraocular Pressure Lowering And Systemic Exposure Of PF-04217329 - NCT00934089-92663
Conditions: Glaucoma, Open-Angle - Ocular Hypertension
Location: Newport Beach, CA
- A Phase 2 Study Of The 24-Hour Intraocular Pressure Lowering And Systemic Exposure Of PF-04217329 - NCT00934089-92844
Conditions: Glaucoma, Open-Angle - Ocular Hypertension
Location: Garden Grove, CA
- A Pilot Observational Study to Evaluate Efficacy and Safety of Clevidipine in Neurosurgical Patients - NCT00952081-10031
Conditions: Hypertension - Brain Tumor - Epilepsy
Location: New York, NY
- A Pilot Study of Chronic Red Blood Cell Transfusion in Sickle Cell Disease-Associated Pulmonary Hypertension - NCT00850369-27710
Conditions: Pulmonary Hypertension - Sickle Cell Disease
Location: Durham, NC
- A Pilot Study to Determine the Efficacy of a Low Carbohydrate Diet in Treatment of Adolescents With Metabolic Syndrome - NCT00940966-25302
Conditions: Elevated Triglycerides - Systolic Hypertension - Insulin Resistance - Abdominal Obesity
Location: CHARLESTON, WV
- A Research Study To Assess The Effectiveness And Safety Of Different Doses Of Oral PF-00489791 In The Treatment Of Adult Patients With Pulmonary Arterial Hypertension - NCT00853112-02111
Conditions: Hypertension, Pulmonary
Location: Boston, MA
- A Research Study To Assess The Effectiveness And Safety Of Different Doses Of Oral PF-00489791 In The Treatment Of Adult Patients With Pulmonary Arterial Hypertension - NCT00853112-15212
Conditions: Hypertension, Pulmonary
Location: Pittsburgh, PA
- A Research Study To Assess The Effectiveness And Safety Of Different Doses Of Oral PF-00489791 In The Treatment Of Adult Patients With Pulmonary Arterial Hypertension - NCT00853112-19141
Conditions: Hypertension, Pulmonary
Location: Philadelphia, PA
- A Research Study To Assess The Effectiveness And Safety Of Different Doses Of Oral PF-00489791 In The Treatment Of Adult Patients With Pulmonary Arterial Hypertension - NCT00853112-30030
Conditions: Hypertension, Pulmonary
Location: Decatur, GA
- A Research Study To Assess The Effectiveness And Safety Of Different Doses Of Oral PF-00489791 In The Treatment Of Adult Patients With Pulmonary Arterial Hypertension - NCT00853112-30033
Conditions: Hypertension, Pulmonary
Location: Decatur, GA
- A Research Study To Assess The Effectiveness And Safety Of Different Doses Of Oral PF-00489791 In The Treatment Of Adult Patients With Pulmonary Arterial Hypertension - NCT00853112-32610
Conditions: Hypertension, Pulmonary
Location: Gainesville, FL
- A Research Study To Assess The Effectiveness And Safety Of Different Doses Of Oral PF-00489791 In The Treatment Of Adult Patients With Pulmonary Arterial Hypertension - NCT00853112-68131
Conditions: Hypertension, Pulmonary
Location: Omaha, NE
- A Research Study To Assess The Effectiveness And Safety Of Different Doses Of Oral PF-00489791 In The Treatment Of Adult Patients With Pulmonary Arterial Hypertension - NCT00853112-75390
Conditions: Hypertension, Pulmonary
Location: Dallas, TX
- A Research Study To Assess The Effectiveness And Safety Of Different Doses Of Oral PF-00489791 In The Treatment Of Adult Patients With Pulmonary Arterial Hypertension - NCT00853112-85006
Conditions: Hypertension, Pulmonary
Location: Phoenix, AZ
- A Research Study To Assess The Effectiveness And Safety Of Different Doses Of Oral PF-00489791 In The Treatment Of Adult Patients With Pulmonary Arterial Hypertension - NCT00853112-85020
Conditions: Hypertension, Pulmonary
Location: Phoenix, AZ
- A Research Study To Assess The Effectiveness And Safety Of Different Doses Of Oral PF-00489791 In The Treatment Of Adult Patients With Pulmonary Arterial Hypertension - NCT00853112-92663
Conditions: Hypertension, Pulmonary
Location: Newport Beach, CA
- A Research Study To Assess The Effectiveness And Safety Of Different Doses Of Oral PF-00489791 In The Treatment Of Adult Patients With Pulmonary Arterial Hypertension - NCT00853112-92708
Conditions: Hypertension, Pulmonary
Location: Fountain Valley, CA
- A Research Study To Assess The Effectiveness And Safety Of Different Doses Of Oral PF-00489791 In The Treatment Of Adult Patients With Pulmonary Arterial Hypertension - NCT00853112-95817
Conditions: Hypertension, Pulmonary
Location: Sacramento, CA
- A Safety Study of the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension or Open Angle Glaucoma - NCT00820300-94025
Conditions: Glaucoma - Ocular Hypertension
Location: Menlo Park, CA
- A Study in the Use of Home Blood Pressure Monitoring and Telephone Follow-up to Control Blood Pressure - NCT00662753-20018
Conditions: Hypertension
Location: Washington, DC
- A Study in the Use of Home Blood Pressure Monitoring and Telephone Follow-up to Control Blood Pressure - NCT00662753-20032
Conditions: Hypertension
Location: Washington, DC
- A Study of Different Formulations of the Latanoprost Punctal Plug Delivery System in Subjects With Ocular Hypertension or Open-Angle Glaucoma - NCT00967811-94025
Conditions: Glaucoma - Ocular Hypertension
Location: Menlo Park, CA
- A Study of the Effects of Eplerenone and Amlodipine on Blood Pressure and Basal Metabolic Rate in Obese Hypertensives - NCT00825188-39216
Conditions: Obesity - Hypertension
Location: Jackson, MS
- A Study of the Latanoprost Punctal Plug Delivery System (L-PPDS) With Adjunctive Xalatan® Eye Drops in Subjects With Ocular Hypertension (OH) or Open-Angle Glaucoma (OAG) - NCT01037036-94025
Conditions: Ocular Hypertension - Open-Angle Glaucoma
Location: Menlo Park, CA
- A Study on the Efficacy and Safety of Nebivolol Monotherapy in Hispanic Hypertensive Patients. - NCT00770861-10451
Conditions: Hypertension
Location: Bronx, NY
- A Study on the Efficacy and Safety of Nebivolol Monotherapy in Hispanic Hypertensive Patients. - NCT00770861-12553
Conditions: Hypertension
Location: New Windsor, NY
- A Study on the Efficacy and Safety of Nebivolol Monotherapy in Hispanic Hypertensive Patients. - NCT00770861-30312
Conditions: Hypertension
Location: Atlanta, GA
- A Study on the Efficacy and Safety of Nebivolol Monotherapy in Hispanic Hypertensive Patients. - NCT00770861-33012A
Conditions: Hypertension
Location: Hialeah, FL
- A Study on the Efficacy and Safety of Nebivolol Monotherapy in Hispanic Hypertensive Patients. - NCT00770861-33012B
Conditions: Hypertension
Location: Hialeah, FL
- A Study on the Efficacy and Safety of Nebivolol Monotherapy in Hispanic Hypertensive Patients. - NCT00770861-33014
Conditions: Hypertension
Location: Miami, FL
- A Study on the Efficacy and Safety of Nebivolol Monotherapy in Hispanic Hypertensive Patients. - NCT00770861-33024
Conditions: Hypertension
Location: Pembroke Pines, FL
- A Study on the Efficacy and Safety of Nebivolol Monotherapy in Hispanic Hypertensive Patients. - NCT00770861-33027
Conditions: Hypertension
Location: Pembroke Pines, FL
- A Study on the Efficacy and Safety of Nebivolol Monotherapy in Hispanic Hypertensive Patients. - NCT00770861-33134
Conditions: Hypertension
Location: Coral Gables, FL
- A Study on the Efficacy and Safety of Nebivolol Monotherapy in Hispanic Hypertensive Patients. - NCT00770861-33156
Conditions: Hypertension
Location: Miami, FL
- A Study on the Efficacy and Safety of Nebivolol Monotherapy in Hispanic Hypertensive Patients. - NCT00770861-33169
Conditions: Hypertension
Location: Miami, FL
- A Study on the Efficacy and Safety of Nebivolol Monotherapy in Hispanic Hypertensive Patients. - NCT00770861-34741
Conditions: Hypertension
Location: Kissimmee, FL
- A Study on the Efficacy and Safety of Nebivolol Monotherapy in Hispanic Hypertensive Patients. - NCT00770861-75006
Conditions: Hypertension
Location: Carrollton, TX
- A Study on the Efficacy and Safety of Nebivolol Monotherapy in Hispanic Hypertensive Patients. - NCT00770861-78224
Conditions: Hypertension
Location: San Antonio, TX
- A Study on the Efficacy and Safety of Nebivolol Monotherapy in Hispanic Hypertensive Patients. - NCT00770861-78229
Conditions: Hypertension
Location: San Antonio, TX
- A Study on the Efficacy and Safety of Nebivolol Monotherapy in Hispanic Hypertensive Patients. - NCT00770861-78404
Conditions: Hypertension
Location: Corpus Christi, TX
- A Study on the Efficacy and Safety of Nebivolol Monotherapy in Hispanic Hypertensive Patients. - NCT00770861-79902
Conditions: Hypertension
Location: El Paso, TX
- A Study on the Efficacy and Safety of Nebivolol Monotherapy in Hispanic Hypertensive Patients. - NCT00770861-90057
Conditions: Hypertension
Location: Los Angeles, CA
- A Study on the Efficacy and Safety of Nebivolol Monotherapy in Hispanic Hypertensive Patients. - NCT00770861-90620
Conditions: Hypertension
Location: Buena Park, CA
- A Study on the Efficacy and Safety of Nebivolol Monotherapy in Hispanic Hypertensive Patients. - NCT00770861-90806
Conditions: Hypertension
Location: Long Beach, CA
- A Study on the Efficacy and Safety of Nebivolol Monotherapy in Hispanic Hypertensive Patients. - NCT00770861-91710
Conditions: Hypertension
Location: Chino, CA
- A Study on the Efficacy and Safety of Nebivolol Monotherapy in Hispanic Hypertensive Patients. - NCT00770861-91950
Conditions: Hypertension
Location: National City, CA
- A Study on the Efficacy and Safety of Nebivolol Monotherapy in Hispanic Hypertensive Patients. - NCT00770861-92780
Conditions: Hypertension
Location: Tustin, CA
- A Study to Assess the Safety and Efficacy of Treprostinil to Facilitate Liver Transplantation in Patients With Portopulmonary Hypertension - NCT01028651-53792
Conditions: Portopulmonary Hypertension - Pulmonary Arterial Hypertension - Pulmonary Hypertension
Location: Madison, WI
- A Study to Assess the Safety and Efficacy of Treprostinil to Facilitate Liver Transplantation in Patients With Portopulmonary Hypertension - NCT01028651-90024
Conditions: Portopulmonary Hypertension - Pulmonary Arterial Hypertension - Pulmonary Hypertension
Location: Los Angeles, CA
- A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With CTEPH. - NCT00855465-
Conditions: Pulmonary Hypertension
Location: Baltimore, MD
- A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With CTEPH. - NCT00855465-02114
Conditions: Pulmonary Hypertension
Location: Boston, MA
- A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With CTEPH. - NCT00855465-15212
Conditions: Pulmonary Hypertension
Location: Pittsburgh, PA
- A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With CTEPH. - NCT00855465-30030
Conditions: Pulmonary Hypertension
Location: Decatur, GA
- A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With CTEPH. - NCT00855465-30342
Conditions: Pulmonary Hypertension
Location: Atlanta, GA
- A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With CTEPH. - NCT00855465-33136
Conditions: Pulmonary Hypertension
Location: Miami, FL
- A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With CTEPH. - NCT00855465-35294
Conditions: Pulmonary Hypertension
Location: Birmingham, AL
- A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With CTEPH. - NCT00855465-43210
Conditions: Pulmonary Hypertension
Location: Columbus, OH
- A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With CTEPH. - NCT00855465-44195
Conditions: Pulmonary Hypertension
Location: Cleveland, OH
- A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With CTEPH. - NCT00855465-45014
Conditions: Pulmonary Hypertension
Location: Fairfield, OH
- A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With CTEPH. - NCT00855465-75390
Conditions: Pulmonary Hypertension
Location: Dallas, TX
- A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With CTEPH. - NCT00855465-80045
Conditions: Pulmonary Hypertension
Location: Aurora, CO
- A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With CTEPH. - NCT00855465-92103
Conditions: Pulmonary Hypertension
Location: San Diego, CA
- A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With CTEPH. - NCT00855465-95817
Conditions: Pulmonary Hypertension
Location: Sacramento, CA
- A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With Pulmonary Arterial Hypertension (PAH) - NCT00810693-
Conditions: Pulmonary Hypertension
Location: Baltimore, MD
- A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With Pulmonary Arterial Hypertension (PAH) - NCT00810693-02111
Conditions: Pulmonary Hypertension
Location: Boston, MA
- A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With Pulmonary Arterial Hypertension (PAH) - NCT00810693-02114
Conditions: Pulmonary Hypertension
Location: Boston, MA
- A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With Pulmonary Arterial Hypertension (PAH) - NCT00810693-15212
Conditions: Pulmonary Hypertension
Location: Pittsburgh, PA
- A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With Pulmonary Arterial Hypertension (PAH) - NCT00810693-30030
Conditions: Pulmonary Hypertension
Location: Decatur, GA
- A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With Pulmonary Arterial Hypertension (PAH) - NCT00810693-30342
Conditions: Pulmonary Hypertension
Location: Atlanta, GA
- A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With Pulmonary Arterial Hypertension (PAH) - NCT00810693-33136
Conditions: Pulmonary Hypertension
Location: Miami, FL
- A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With Pulmonary Arterial Hypertension (PAH) - NCT00810693-35233
Conditions: Pulmonary Hypertension
Location: Birmingham, AL
- A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With Pulmonary Arterial Hypertension (PAH) - NCT00810693-43210
Conditions: Pulmonary Hypertension
Location: Columbus, OH
- A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With Pulmonary Arterial Hypertension (PAH) - NCT00810693-44195
Conditions: Pulmonary Hypertension
Location: Cleveland, OH
- A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With Pulmonary Arterial Hypertension (PAH) - NCT00810693-45014
Conditions: Pulmonary Hypertension
Location: Fairfield, OH
- A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With Pulmonary Arterial Hypertension (PAH) - NCT00810693-55905
Conditions: Pulmonary Hypertension
Location: Rochester, MN
- A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With Pulmonary Arterial Hypertension (PAH) - NCT00810693-75390
Conditions: Pulmonary Hypertension
Location: Dallas, TX
- A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With Pulmonary Arterial Hypertension (PAH) - NCT00810693-80045
Conditions: Pulmonary Hypertension
Location: Aurora, CO
- A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With Pulmonary Arterial Hypertension (PAH) - NCT00810693-90073
Conditions: Pulmonary Hypertension
Location: Los Angeles, CA
- A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With Pulmonary Arterial Hypertension (PAH) - NCT00810693-90502
Conditions: Pulmonary Hypertension
Location: Torrance, CA
- A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With Pulmonary Arterial Hypertension (PAH) - NCT00810693-95817
Conditions: Pulmonary Hypertension
Location: Sacramento, CA
- A Study to Evaluate the Safety/Tolerability and Pharmacokinetics of Aliskiren in Hypertensive Pediatric and Adolescent Patients 6 - 17 Years of Age - NCT00834041-
Conditions: Hypertension
Location: Daytona Beach, FL
- Acupuncture and Laser Acupoint Treatment on Hypertension - NCT00459680-63017
Conditions: Hypertension
Location: Chesterfield, MO
- ADMA Levels in End-Stage Renal Disease - NCT00350974-48109
Conditions: Chronic Kidney Disease - Hypertension
Location: Ann Arbor, MI
- Aerobic Exercise in Patients With Pulmonary Hypertension - NCT00678821-20892
Conditions: Hypertension, Pulmonary
Location: Bethesda, MD
- Aerobic Exercise in Patients With Pulmonary Hypertension - NCT00678821-22042
Conditions: Hypertension, Pulmonary
Location: Falls Church, VA
- After Discharge Management of Low Income Frail Elderly - NCT00328848-44304
Conditions: Heart Failure, Congestive - Coronary Arteriosclerosis - Atrial Fibrillation - Cerebrovascular Accident - Pulmonary Disease, Chronic Obstructive - Diabetes Mellitus - Hypertension - Osteoarthritis - Osteoporosis
Location: Akron, OH
- Aldosterone Blockade to Prevent Myocardial Remodeling In Patients With Controlled Essential Hypertension - NCT00980031-68131
Conditions: Myocardial Remodeling
Location: Omaha, NE
- Aliskiren/Amlodipine/Hydrochlorothiazide (HCTZ) Versus Aliskiren/Amlodipine in US Minority Patients With Stage II Systolic Hypertension - NCT00942994-02126
Conditions: Hypertension
Location: Mattapan, MA
- Aliskiren/Amlodipine/Hydrochlorothiazide (HCTZ) Versus Aliskiren/Amlodipine in US Minority Patients With Stage II Systolic Hypertension - NCT00942994-20110
Conditions: Hypertension
Location: Manassas, VA
- Aliskiren/Amlodipine/Hydrochlorothiazide (HCTZ) Versus Aliskiren/Amlodipine in US Minority Patients With Stage II Systolic Hypertension - NCT00942994-33143
Conditions: Hypertension
Location: South Miami, FL
- Aliskiren/Amlodipine/Hydrochlorothiazide (HCTZ) Versus Aliskiren/Amlodipine in US Minority Patients With Stage II Systolic Hypertension - NCT00942994-72201
Conditions: Hypertension
Location: Little Rock, AR
- Aliskiren/Amlodipine/Hydrochlorothiazide (HCTZ) Versus Aliskiren/Amlodipine in US Minority Patients With Stage II Systolic Hypertension - NCT00942994-98133
Conditions: Hypertension
Location: Seattle, WA
- Alpha-Adrenoceptor Vascular Function In Chronic Kidney Disease Focus On The Role Of Endothelial Nitric Oxide - NCT00356265-48109
Conditions: Chronic Kidney Disease - Hypertension
Location: Ann Arbor, MI
- Ambrisentan (Letairis) for Sarcoidosis Associated Pulmonary Hypertension - NCT00851929-
Conditions: Sarcoidosis - Pulmonary Hypertension
Location: Chapel Hill, NC
- Ambrisentan (Letairis) for Sarcoidosis Associated Pulmonary Hypertension - NCT00851929-29466
Conditions: Sarcoidosis - Pulmonary Hypertension
Location: Charleston, SC
- Ambulatory Blood Pressure Monitoring in Hypertension - NCT00166634-40202
Conditions: Hypertension
Location: Louisville, KY
- Ambulatory Blood Pressure Monitoring in Hypertension - NCT00166634-44106
Conditions: Hypertension
Location: Cleveland, OH
- Ambulatory Blood Pressure Monitoring in Hypertension - NCT00166634-72202
Conditions: Hypertension
Location: Little Rock, AR
- Ambulatory Blood Pressure Monitoring in Hypertension - NCT00166634-84132
Conditions: Hypertension
Location: Salt Lake City, UT
- An Evaluation of the Fixed Combination Brimonidine Tartrate 0.2%/ Timolol Maleate 0.5% to Latanoprost 0.005% in Glaucoma or Ocular Hypertension Subjects - NCT00811564-
Conditions: Glaucoma - Ocular Hypertension
Location: Slingerlands, NY
- An Intervention to Improve Communication Between Physicians and Minority Patients With Hypertension - NCT01037920-80204
Conditions: Hypertension
Location: Denver, CO
- An Open-Label Extension of BPS-MR-PAH-201 in Pulmonary Arterial Hypertension (PAH) Patients - NCT00792571-15212
Conditions: Pulmonary Arterial Hypertension
Location: Pittsburgh, PA
- An Open-Label Extension of BPS-MR-PAH-201 in Pulmonary Arterial Hypertension (PAH) Patients - NCT00792571-75390
Conditions: Pulmonary Arterial Hypertension
Location: Dallas, TX
- An Open-Label Extension of BPS-MR-PAH-201 in Pulmonary Arterial Hypertension (PAH) Patients - NCT00792571-90502
Conditions: Pulmonary Arterial Hypertension
Location: Torrance, CA
- Anticoagulation For Pulmonary Hypertension in Sickle Cell Disease - NCT01036802-27599
Conditions: Pulmonary Hypertension
Location: Chapel Hill, NC
- ARTEMIS-PH - Study of Ambrisentan in Subjects With Pulmonary Hypertension Associated With Idiopathic Pulmonary Fibrosis - NCT00879229-30030
Conditions: Idiopathic Pulmonary Fibrosis - Pulmonary Hypertension
Location: Decatur, GA
- ARTEMIS-PH - Study of Ambrisentan in Subjects With Pulmonary Hypertension Associated With Idiopathic Pulmonary Fibrosis - NCT00879229-33756
Conditions: Idiopathic Pulmonary Fibrosis - Pulmonary Hypertension
Location: Clearwater, FL
- ARTEMIS-PH - Study of Ambrisentan in Subjects With Pulmonary Hypertension Associated With Idiopathic Pulmonary Fibrosis - NCT00879229-45219
Conditions: Idiopathic Pulmonary Fibrosis - Pulmonary Hypertension
Location: Cincinnati, OH
- Assess the Efficacy and Safety of Sildenafil When Added to Bosentan in the Treatment of Pulmonary Arterial Hypertension - NCT00323297-15212
Conditions: Pulmonary Arterial Hypertension
Location: Pittsburgh, PA
- Assess the Efficacy and Safety of Sildenafil When Added to Bosentan in the Treatment of Pulmonary Arterial Hypertension - NCT00323297-48202
Conditions: Pulmonary Arterial Hypertension
Location: Detroit, MI
- Assess the Efficacy and Safety of Sildenafil When Added to Bosentan in the Treatment of Pulmonary Arterial Hypertension - NCT00323297-77030
Conditions: Pulmonary Arterial Hypertension
Location: Houston, TX
- Assess the Efficacy and Safety of Sildenafil When Added to Bosentan in the Treatment of Pulmonary Arterial Hypertension - NCT00323297-78229
Conditions: Pulmonary Arterial Hypertension
Location: San Antonio, TX
- Assess the Efficacy and Safety of Sildenafil When Added to Bosentan in the Treatment of Pulmonary Arterial Hypertension - NCT00323297-90073
Conditions: Pulmonary Arterial Hypertension
Location: Los Angeles, CA
- Assessing Outcome After H-Graft Shunt Placement - NCT00519610-33606
Conditions: Portal Hypertension
Location: Tampa, FL
- Atheroma Reduction With Chloroquine in Patients With the Metabolic Syndrome (ARCH-MS) - NCT00455403-63110
Conditions: Metabolic Syndrome X - Overweight - Hypertension - Dyslipidemias - Prediabetic State
Location: St. Louis, MO
- Behavioral Study to Control Blood Pressure - NCT01035554-17033
Conditions: Hypertension
Location: Hershey, PA
- Benefits of Medical Therapy Plus Stenting for Renal Atherosclerotic Lesions - NCT00081731-43614
Conditions: Atherosclerosis - Cardiovascular Diseases - Hypertension, Renovascular - Renal Artery Obstruction
Location: Toledo, OH
- Bioimpedance Evaluation of Therapeutic Titration in Essential, Refractory Hypertension - NCT00913094-48201
Conditions: Hypertension
Location: Detroit, MI
- Biomarkers in the Evaluation of Chronic Lung Disease - NCT00926523-11040
Conditions: Pulmonary Hypertension - Pulmonary Arterial Hypertension - Interstitial Lung Disease
Location: New Hyde Park, NY
- Blood Pressure Control in African Americans - NCT00233220-10032
Conditions: Cardiovascular Diseases - Hypertension
Location: New York, NY
- Body Volume Regulation in Pulmonary Arterial Hypertenison With Right Ventricular Failure - NCT00811486-80262
Conditions: Right Heart Failure - Pulmonary Hypertension
Location: Denver, CO
- B-type Natriuretic Peptide (BNP) in Human Hypertension - NCT00953472-55905
Conditions: Hypertension Stage 1
Location: Rochester, MN
- Cardioprotective Benefits of Carvedilol-CR or Valsartan Added to Lisinopril - NCT00657241-14215
Conditions: Hypertension
Location: Buffalo, NY
- Cardiopulmonary Function Assessment and NO-Based Therapies for Patients With Hemolysis-Associated Pulmonary Hypertension - NCT00352430-20892
Conditions: Pulmonary Hypertension
Location: Bethesda, MD
- Cerebral Hemodynamic Effects of Hypertonic Solutions in Severely Head-Injured Patients - NCT00125229-78229
Conditions: Traumatic Brain Injury - Intracranial Hypertension
Location: San Antonio, TX
- Changes in Eye Pressure and Anterior Chamber Depth With Oral Endothelin Antagonist Therapy - NCT00452283-80045
Conditions: Glaucoma - Pulmonary Hypertension
Location: Aurora, CO
- Chiropractic for Hypertension in Patients - NCT01020435-33140
Conditions: Hypertension
Location: Miami, FL
- Chiropractic for Hypertension in Patients - NCT01020435-52722
Conditions: Hypertension
Location: Bettendorf, IA
- Chiropractic for Hypertension in Patients - NCT01020435-52803
Conditions: Hypertension
Location: Davenport, IA
- Chloroquine to Treat People With Metabolic Syndrome (ARCH-MS) - NCT00455325-63110
Conditions: Metabolic Syndrome X - Overweight - Hypertension - Dyslipidemias - Prediabetic State
Location: St. Louis, MO
- Chronic Sildenafil for Severe Diaphragmatic Hernia - NCT00133679-60614
Conditions: Hernia, Diaphragmatic - Hypertension, Pulmonary - Hypoplasia, Pulmonary
Location: Chicago, IL
- Chronic Sildenafil for Severe Diaphragmatic Hernia - NCT00133679-90027
Conditions: Hernia, Diaphragmatic - Hypertension, Pulmonary - Hypoplasia, Pulmonary
Location: Los Angeles, CA
- Chronic Sildenafil for Severe Diaphragmatic Hernia - NCT00133679-94143
Conditions: Hernia, Diaphragmatic - Hypertension, Pulmonary - Hypoplasia, Pulmonary
Location: San Francisco, CA
- Clevidipine in the Treatment of Blood Pressure in Patients With Acute Heart Failure - NCT00803634-11794
Conditions: Hypertension - Heart Failure
Location: Stony Brook, NY
- Clevidipine in the Treatment of Blood Pressure in Patients With Acute Heart Failure - NCT00803634-27710
Conditions: Hypertension - Heart Failure
Location: Durham, NC
- Clevidipine in the Treatment of Blood Pressure in Patients With Acute Heart Failure - NCT00803634-37232
Conditions: Hypertension - Heart Failure
Location: Nashville, TN
- Clevidipine in the Treatment of Blood Pressure in Patients With Acute Heart Failure - NCT00803634-44109
Conditions: Hypertension - Heart Failure
Location: Cleveland, OH
- Clevidipine in the Treatment of Blood Pressure in Patients With Acute Heart Failure - NCT00803634-44195
Conditions: Hypertension - Heart Failure
Location: Cleveland, OH
- Clevidipine in the Treatment of Blood Pressure in Patients With Acute Heart Failure - NCT00803634-45267
Conditions: Hypertension - Heart Failure
Location: Cincinnati, OH
- Clevidipine in the Treatment of Blood Pressure in Patients With Acute Heart Failure - NCT00803634-48202
Conditions: Hypertension - Heart Failure
Location: Detroit, MI
- Clevidipine in the Treatment of Blood Pressure in Patients With Acute Heart Failure - NCT00803634-63110
Conditions: Hypertension - Heart Failure
Location: St. Louis, MO
- Clevidipine in the Treatment of Blood Pressure in Patients With Acute Heart Failure - NCT00803634-70112
Conditions: Hypertension - Heart Failure
Location: New Orleans, LA
- Clevidipine in the Treatment of Blood Pressure in Patients With Acute Heart Failure - NCT00803634-70805
Conditions: Hypertension - Heart Failure
Location: Baton Rouge, LA
- Clevidipine in the Treatment of Blood Pressure in Patients With Acute Heart Failure - NCT00803634-75390
Conditions: Hypertension - Heart Failure
Location: Dallas, TX
- Clevidipine in the Treatment of Blood Pressure in Patients With Acute Heart Failure - NCT00803634-90301
Conditions: Hypertension - Heart Failure
Location: Inglewood, CA
- Clevidipine in the Treatment of Patients With Acute Hypertension and Intracerebral Hemorrhage - NCT00666328-10032
Conditions: Hypertension - Hemorrhage
Location: New York, NY
- Clevidipine in the Treatment of Patients With Acute Hypertension and Intracerebral Hemorrhage - NCT00666328-19107
Conditions: Hypertension - Hemorrhage
Location: Philadelphia, PA
- Clevidipine in the Treatment of Patients With Acute Hypertension and Intracerebral Hemorrhage - NCT00666328-20010
Conditions: Hypertension - Hemorrhage
Location: Washington, DC
- Clevidipine in the Treatment of Patients With Acute Hypertension and Intracerebral Hemorrhage - NCT00666328-21287
Conditions: Hypertension - Hemorrhage
Location: Baltimore, MD
- Clevidipine in the Treatment of Patients With Acute Hypertension and Intracerebral Hemorrhage - NCT00666328-27405
Conditions: Hypertension - Hemorrhage
Location: Greensboro, NC
- Clevidipine in the Treatment of Patients With Acute Hypertension and Intracerebral Hemorrhage - NCT00666328-27710
Conditions: Hypertension - Hemorrhage
Location: Durham, NC
- Clevidipine in the Treatment of Patients With Acute Hypertension and Intracerebral Hemorrhage - NCT00666328-29425A
Conditions: Hypertension - Hemorrhage
Location: Charleston, SC
- Clevidipine in the Treatment of Patients With Acute Hypertension and Intracerebral Hemorrhage - NCT00666328-29425B
Conditions: Hypertension - Hemorrhage
Location: Charleston, SC
- Clevidipine in the Treatment of Patients With Acute Hypertension and Intracerebral Hemorrhage - NCT00666328-43210
Conditions: Hypertension - Hemorrhage
Location: Columbus, OH
- Clevidipine in the Treatment of Patients With Acute Hypertension and Intracerebral Hemorrhage - NCT00666328-44195
Conditions: Hypertension - Hemorrhage
Location: Cleveland, OH
- Clevidipine in the Treatment of Patients With Acute Hypertension and Intracerebral Hemorrhage - NCT00666328-48202
Conditions: Hypertension - Hemorrhage
Location: Detroit, MI
- Clevidipine in the Treatment of Patients With Acute Hypertension and Intracerebral Hemorrhage - NCT00666328-77030
Conditions: Hypertension - Hemorrhage
Location: Houston, TX
- Clevidipine in the Treatment of Patients With Acute Hypertension and Intracerebral Hemorrhage - NCT00666328-78229
Conditions: Hypertension - Hemorrhage
Location: San Antonio, TX
- Clevidipine in the Treatment of Patients With Acute Hypertension and Intracerebral Hemorrhage - NCT00666328-84157
Conditions: Hypertension - Hemorrhage
Location: Murray, UT
- Clevidipine in the Treatment of Patients With Acute Hypertension and Intracerebral Hemorrhage - NCT00666328-96813
Conditions: Hypertension - Hemorrhage
Location: Honolulu, HI
- Clinical Decision Support Consortium - NCT00853619-02481
Conditions: Diabetes - Coronary Artery Disease - Hypertension
Location: Wellesley, MA
- Clinical Validation of the Tiba Medical Ambulo 2400 ABPM According to the ISO 80601-2-30 Standard in Adults, Adolescents, and Children - NCT00944983-38105
Conditions: Hypertension
Location: Memphis, TN
- Combination Therapy in Pulmonary Arterial Hypertension - NCT00433329-02115
Conditions: Pulmonary Arterial Hypertension
Location: Boston, MA
- Combination Therapy in Pulmonary Arterial Hypertension - NCT00433329-10032
Conditions: Pulmonary Arterial Hypertension
Location: New York, NY
- Combination Therapy in Pulmonary Arterial Hypertension - NCT00433329-14203
Conditions: Pulmonary Arterial Hypertension
Location: Buffalo, NY
- Combination Therapy in Pulmonary Arterial Hypertension - NCT00433329-15213A
Conditions: Pulmonary Arterial Hypertension
Location: Pittsburgh, PA
- Combination Therapy in Pulmonary Arterial Hypertension - NCT00433329-15213B
Conditions: Pulmonary Arterial Hypertension
Location: Pittsburgh, PA
- Combination Therapy in Pulmonary Arterial Hypertension - NCT00433329-19713
Conditions: Pulmonary Arterial Hypertension
Location: Newark, DE
- Combination Therapy in Pulmonary Arterial Hypertension - NCT00433329-21201
Conditions: Pulmonary Arterial Hypertension
Location: Baltimore, MD
- Combination Therapy in Pulmonary Arterial Hypertension - NCT00433329-23507
Conditions: Pulmonary Arterial Hypertension
Location: Norfolk, VA
- Combination Therapy in Pulmonary Arterial Hypertension - NCT00433329-30030
Conditions: Pulmonary Arterial Hypertension
Location: Decatur, GA
- Combination Therapy in Pulmonary Arterial Hypertension - NCT00433329-30322
Conditions: Pulmonary Arterial Hypertension
Location: Atlanta, GA
- Combination Therapy in Pulmonary Arterial Hypertension - NCT00433329-32258
Conditions: Pulmonary Arterial Hypertension
Location: Jacksonville, FL
- Combination Therapy in Pulmonary Arterial Hypertension - NCT00433329-33136
Conditions: Pulmonary Arterial Hypertension
Location: Miami, FL
- Combination Therapy in Pulmonary Arterial Hypertension - NCT00433329-33331
Conditions: Pulmonary Arterial Hypertension
Location: Weston, FL
- Combination Therapy in Pulmonary Arterial Hypertension - NCT00433329-33756
Conditions: Pulmonary Arterial Hypertension
Location: Clearwater, FL
- Combination Therapy in Pulmonary Arterial Hypertension - NCT00433329-34239
Conditions: Pulmonary Arterial Hypertension
Location: Sarasota, FL
- Combination Therapy in Pulmonary Arterial Hypertension - NCT00433329-35294
Conditions: Pulmonary Arterial Hypertension
Location: Birmingham, AL
- Combination Therapy in Pulmonary Arterial Hypertension - NCT00433329-36617
Conditions: Pulmonary Arterial Hypertension
Location: Mobile, AL
- Combination Therapy in Pulmonary Arterial Hypertension - NCT00433329-40202
Conditions: Pulmonary Arterial Hypertension
Location: Louisville, KY
- Combination Therapy in Pulmonary Arterial Hypertension - NCT00433329-43210
Conditions: Pulmonary Arterial Hypertension
Location: Columbus, OH
- Combination Therapy in Pulmonary Arterial Hypertension - NCT00433329-44195
Conditions: Pulmonary Arterial Hypertension
Location: Cleveland, OH
- Combination Therapy in Pulmonary Arterial Hypertension - NCT00433329-53226
Conditions: Pulmonary Arterial Hypertension
Location: Milwaukee, WI
- Combination Therapy in Pulmonary Arterial Hypertension - NCT00433329-55905
Conditions: Pulmonary Arterial Hypertension
Location: Rochester, MN
- Combination Therapy in Pulmonary Arterial Hypertension - NCT00433329-63110
Conditions: Pulmonary Arterial Hypertension
Location: St. Louis, MO
- Combination Therapy in Pulmonary Arterial Hypertension - NCT00433329-73112
Conditions: Pulmonary Arterial Hypertension
Location: Oklahoma City, OK
- Combination Therapy in Pulmonary Arterial Hypertension - NCT00433329-75390
Conditions: Pulmonary Arterial Hypertension
Location: Dallas, TX
- Combination Therapy in Pulmonary Arterial Hypertension - NCT00433329-77030
Conditions: Pulmonary Arterial Hypertension
Location: Houston, TX
- Combination Therapy in Pulmonary Arterial Hypertension - NCT00433329-84604
Conditions: Pulmonary Arterial Hypertension
Location: Provo, UT
- Combination Therapy in Pulmonary Arterial Hypertension - NCT00433329-90048
Conditions: Pulmonary Arterial Hypertension
Location: Los Angeles, CA
- Combination Therapy in Pulmonary Arterial Hypertension - NCT00433329-90095
Conditions: Pulmonary Arterial Hypertension
Location: Los Angeles, CA
- Combination Therapy in Pulmonary Arterial Hypertension - NCT00433329-97220
Conditions: Pulmonary Arterial Hypertension
Location: Portland, OR
- Combined Renin Inhibition/Beta-Blockade - NCT00627861-10021
Conditions: Hypertension
Location: New York, NY
- Community Partnership to Examine Racial and Ethnic Differences in Health Care for Hypertension and Diabetes - NCT00379652-02115
Conditions: Hypertension - Diabetes Mellitis
Location: Boston, MA
- Community Partnership to Examine Racial and Ethnic Differences in Health Care for Hypertension and Diabetes - NCT00379652-02118
Conditions: Hypertension - Diabetes Mellitis
Location: Boston, MA
- Comparative Effects of Nebivolol and Metoprolol on Femal Sexual Function - NCT00995072-32223
Conditions: Hypertension - Female Sexual Dysfunction
Location: Jacksonville, FL
- Comparative Effects of Nebivolol Versus Placebo on Sodium Sensitivity of Blood Pressure in Hispanic Postmenopausal Women With Hypertension - NCT00992056-33136
Conditions: Hypertension
Location: 1500 NW 12th Ave 15-West. Miam, FL
- Comparing Efficacy and Safety of Combigan With Timolol Adjunctive to Xalatan in Glaucoma or Ocular Hypertension Subjects - NCT00735449-
Conditions: Glaucoma - Ocular Hypertension
Location: Newark, NJ
- Comparing the Effects of Two Beta Blockers,Metoprolol and Nebivolol,on Ambulatory Blood Pressure and Basal Metabolic Rate - NCT00849810-39216
Conditions: Hypertension
Location: Jackson, MS
- Comparison Fetal Hemodynamic Measurements Antihypertensive Versus Control - NCT00759278-13202
Conditions: Hypertension - Pregnancy
Location: Syracuse, NY
- Comparison of the Alpha-2 Agonists for Prevention of Intraocular Pressure Elevation After Selective Laser Trabeculoplasty - NCT00567411-20307
Conditions: Glaucoma - Ocular Hypertension
Location: Washington, DC
- Coreg CR, Blood Vessel Stiffness and Blood Vessel Function - NCT00732511-11203
Conditions: Endothelial Function - Diabetes Mellitus - Hypertension
Location: Brooklyn, NY
- Dallas Heart Study 2: Return Clinic Visit for the Dallas Heart Study Cohort - NCT00344903-75390
Conditions: Atherosclerosis - Congestive Heart Failure - Left Ventricular Hypertrophy - Diabetes Mellitus - Hypertension - Obesity - Metabolic Syndrome X - Myocardial Infarction
Location: Dallas, TX
- DHA Supplements to Improve Insulin Sensitivity in Obese Pregnant Women (The Omega-3 Pregnancy Study) - NCT00865683-45229
Conditions: Overweight and Obesity - Insulin Resistance - Diabetes, Gestational - Hypertension in Pregnancy - Pre-Eclampsia
Location: Cincinnati, OH
- Diagnosis and Treatment of Sleep Apnea in Cerebrovascular Disease - NCT00984308-06516
Conditions: Obstructive Sleep Apnea - Hypertension
Location: West Haven, CT
- Diagnosis and Treatment of Sleep Apnea in Cerebrovascular Disease - NCT00984308-46202
Conditions: Obstructive Sleep Apnea - Hypertension
Location: Indianapolis, IN
- Does Sildenafil Increase Exercise Performance in Air Pollution? - NCT00808912-18509
Conditions: Pulmonary Hypertension - Pulmonary Artery Pressure - Exercise Performance - Air Pollution
Location: Scranton, PA
- Dose Response of Valsartan on Sitting Systolic Blood Pressure in Children 6 Months - 5 Years of Age With High Blood Pressure - NCT00435162-
Conditions: Hypertension
Location: Charleston, WV
- Dose-response Study of the Safety and Efficacy of Beraprost Sodium Modified Release (BPS-MR) in Patients With Pulmonary Arterial Hypertension (PAH) - NCT00989963-15212
Conditions: Pulmonary Arterial Hypertension
Location: Pittsburgh, PA
- Dose-response Study of the Safety and Efficacy of Beraprost Sodium Modified Release (BPS-MR) in Patients With Pulmonary Arterial Hypertension (PAH) - NCT00989963-75390
Conditions: Pulmonary Arterial Hypertension
Location: Dallas, TX
- Dose-response Study of the Safety and Efficacy of Beraprost Sodium Modified Release (BPS-MR) in Patients With Pulmonary Arterial Hypertension (PAH) - NCT00989963-90502
Conditions: Pulmonary Arterial Hypertension
Location: Torrance, CA
- Double Blind, Randomized Trial of Bosentan for Sarcoidosis Associated Pulmonary Hypertension - NCT00581607-
Conditions: Sarcoidosis - Pulmonary Arterial Hypertension
Location: Pittsburgh, PA
- Double Blind, Randomized Trial of Bosentan for Sarcoidosis Associated Pulmonary Hypertension - NCT00581607-45267
Conditions: Sarcoidosis - Pulmonary Arterial Hypertension
Location: Cincinnati, OH
- DuoTrav APS Versus XALACOM® in Ocular Surface Health - NCT00912054-76134
Conditions: Open Angle Glaucoma - Ocular Hypertension
Location: Fort Worth, TX
- DuoTrav® Eye Drops As Replacement Therapy Program - NCT00828906-76134
Conditions: Open-Angle Glaucoma - Ocular Hypertension
Location: Fort Worth, TX
- Early, Simple and Reliable Detection of Pulmonary Arterial Hypertension (PAH) in Systemic Sclerosis (SSc) - NCT00706082-02118
Conditions: Systemic Sclerosis - Pulmonary Arterial Hypertension - Pulmonary Hypertension
Location: Boston, MA
- Early, Simple and Reliable Detection of Pulmonary Arterial Hypertension (PAH) in Systemic Sclerosis (SSc) - NCT00706082-06030
Conditions: Systemic Sclerosis - Pulmonary Arterial Hypertension - Pulmonary Hypertension
Location: Farmington, CT
- Early, Simple and Reliable Detection of Pulmonary Arterial Hypertension (PAH) in Systemic Sclerosis (SSc) - NCT00706082-11042
Conditions: Systemic Sclerosis - Pulmonary Arterial Hypertension - Pulmonary Hypertension
Location: Lake Success, NY
- Early, Simple and Reliable Detection of Pulmonary Arterial Hypertension (PAH) in Systemic Sclerosis (SSc) - NCT00706082-12206
Conditions: Systemic Sclerosis - Pulmonary Arterial Hypertension - Pulmonary Hypertension
Location: Albany, NY
- Early, Simple and Reliable Detection of Pulmonary Arterial Hypertension (PAH) in Systemic Sclerosis (SSc) - NCT00706082-14618
Conditions: Systemic Sclerosis - Pulmonary Arterial Hypertension - Pulmonary Hypertension
Location: Rochester, NY
- Early, Simple and Reliable Detection of Pulmonary Arterial Hypertension (PAH) in Systemic Sclerosis (SSc) - NCT00706082-19107
Conditions: Systemic Sclerosis - Pulmonary Arterial Hypertension - Pulmonary Hypertension
Location: Philadelphia, PA
- Early, Simple and Reliable Detection of Pulmonary Arterial Hypertension (PAH) in Systemic Sclerosis (SSc) - NCT00706082-20007
Conditions: Systemic Sclerosis - Pulmonary Arterial Hypertension - Pulmonary Hypertension
Location: Washington, DC
- Early, Simple and Reliable Detection of Pulmonary Arterial Hypertension (PAH) in Systemic Sclerosis (SSc) - NCT00706082-21224
Conditions: Systemic Sclerosis - Pulmonary Arterial Hypertension - Pulmonary Hypertension
Location: Baltimore, MD
- Early, Simple and Reliable Detection of Pulmonary Arterial Hypertension (PAH) in Systemic Sclerosis (SSc) - NCT00706082-28401
Conditions: Systemic Sclerosis - Pulmonary Arterial Hypertension - Pulmonary Hypertension
Location: Wilmington, NC
- Early, Simple and Reliable Detection of Pulmonary Arterial Hypertension (PAH) in Systemic Sclerosis (SSc) - NCT00706082-29425
Conditions: Systemic Sclerosis - Pulmonary Arterial Hypertension - Pulmonary Hypertension
Location: Charleston, SC
- Early, Simple and Reliable Detection of Pulmonary Arterial Hypertension (PAH) in Systemic Sclerosis (SSc) - NCT00706082-32209
Conditions: Systemic Sclerosis - Pulmonary Arterial Hypertension - Pulmonary Hypertension
Location: Jacksonville, FL
- Early, Simple and Reliable Detection of Pulmonary Arterial Hypertension (PAH) in Systemic Sclerosis (SSc) - NCT00706082-35294
Conditions: Systemic Sclerosis - Pulmonary Arterial Hypertension - Pulmonary Hypertension
Location: Birmingham, AL
- Early, Simple and Reliable Detection of Pulmonary Arterial Hypertension (PAH) in Systemic Sclerosis (SSc) - NCT00706082-43614
Conditions: Systemic Sclerosis - Pulmonary Arterial Hypertension - Pulmonary Hypertension
Location: Toledo, OH
- Early, Simple and Reliable Detection of Pulmonary Arterial Hypertension (PAH) in Systemic Sclerosis (SSc) - NCT00706082-48106
Conditions: Systemic Sclerosis - Pulmonary Arterial Hypertension - Pulmonary Hypertension
Location: Ann Arbor, MI
- Early, Simple and Reliable Detection of Pulmonary Arterial Hypertension (PAH) in Systemic Sclerosis (SSc) - NCT00706082-49546
Conditions: Systemic Sclerosis - Pulmonary Arterial Hypertension - Pulmonary Hypertension
Location: Grand Rapids, MI
- Early, Simple and Reliable Detection of Pulmonary Arterial Hypertension (PAH) in Systemic Sclerosis (SSc) - NCT00706082-53226
Conditions: Systemic Sclerosis - Pulmonary Arterial Hypertension - Pulmonary Hypertension
Location: Milwaukee, WI
- Early, Simple and Reliable Detection of Pulmonary Arterial Hypertension (PAH) in Systemic Sclerosis (SSc) - NCT00706082-55455
Conditions: Systemic Sclerosis - Pulmonary Arterial Hypertension - Pulmonary Hypertension
Location: Minneapolis, MN
- Early, Simple and Reliable Detection of Pulmonary Arterial Hypertension (PAH) in Systemic Sclerosis (SSc) - NCT00706082-55905
Conditions: Systemic Sclerosis - Pulmonary Arterial Hypertension - Pulmonary Hypertension
Location: Rochester, MN
- Early, Simple and Reliable Detection of Pulmonary Arterial Hypertension (PAH) in Systemic Sclerosis (SSc) - NCT00706082-60612
Conditions: Systemic Sclerosis - Pulmonary Arterial Hypertension - Pulmonary Hypertension
Location: Chicago, IL
- Early, Simple and Reliable Detection of Pulmonary Arterial Hypertension (PAH) in Systemic Sclerosis (SSc) - NCT00706082-90095
Conditions: Systemic Sclerosis - Pulmonary Arterial Hypertension - Pulmonary Hypertension
Location: Los Angeles, CA
- Early, Simple and Reliable Detection of Pulmonary Arterial Hypertension (PAH) in Systemic Sclerosis (SSc) - NCT00706082-90509
Conditions: Systemic Sclerosis - Pulmonary Arterial Hypertension - Pulmonary Hypertension
Location: Torrance, CA
- Early, Simple and Reliable Detection of Pulmonary Arterial Hypertension (PAH) in Systemic Sclerosis (SSc) - NCT00706082-98101
Conditions: Systemic Sclerosis - Pulmonary Arterial Hypertension - Pulmonary Hypertension
Location: Seattle, WA
- Early, Simple and Reliable Detection of Pulmonary Arterial Hypertension (PAH) in Systemic Sclerosis (SSc) - NCT00706082-99204
Conditions: Systemic Sclerosis - Pulmonary Arterial Hypertension - Pulmonary Hypertension
Location: Spokane, WA
|
|
|
|
|
Didn't find what you were looking for? Try these alternatives:
Become A Member: To be notified of upcoming clinical trials in your
area please create a free member account.
Browse Studies: If you would like to browse all featured clinical trials
please Browse Studies.
Message Board: Join the discussion in our Health
and Clinical Trials Message Board.
|
|
|